Summit Therapeutics Inc vs WD 40 Company — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while WD 40 Company trades at $237.72 (market cap $3.22B). The key difference: Summit Therapeutics Inc is far larger — about 3.3× WD 40 Company's market cap, and WD 40 Company pays a 1.7% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SMMT | WDFC | |
|---|---|---|
Market Cap | $10.48B | $3.22B |
Sector | Health | Technology |
52-Week High | $29.32 | $264.91 |
52-Week Low | $13.05 | $187.52 |
Enterprise Value | $9.90B | $3.27B |
Dividend Yield | — | 1.7% |
Trailing returns across standard periods
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →WD-40 Company is a global marketing organization dedicated to creating 'positive lasting memories' by developing and selling products that solve maintenance and cleaning problems. Built around the legendary WD-40 Multi-Use Product, the company operates an asset-light business model, focusing on brand management and innovation while utilizing a network of contract manufacturers to deliver solutions across the Americas, EIMEA, and Asia-Pacific.
Read more on WDFC →